Liisa Hurme

Board Member

Board member since
2025

Nationality
Finnish

Born
1967

Independent

Board committees, LEO Pharma

Member of the Audit Committee. 

Positions and management duties

President and CEO of Orion Corporation since 2022. Chair of the Board of the Chemical Industry Federation of Finland. Board member of of Saiph Therapeutics Oy and chair of Snappertuna Holding Oy, Tuohilampi Holding Oy, Orion Pharma (UK) Ltd. and Orion Pharma, Inc. Member of the Confederation of Finnish Industries, the Finnish Business and Policy Forum EVA and of the Finnish Chamber of Commerce. 

Career

Earlier roles at Orion Corporation include Senior Vice President of Global Operations, Senior Vice President of Specialty Products and Senior Vice President of Proprietary Products. Started her career at Pharmacia & Upjohn Diagnostics in Sweden and also worked in Germany and France.

Special competencies

Extensive international experience in pharmaceutical divisional P&L responsible roles, R&D, business development and global operations. Led projects including specialty product launches, optimization of global supply chains and transformation of proprietary product pipelines at Orion, driving strategy and innovation

Meet our Board of Directors

The Board of Directors is accountable for LEO Pharma’s corporate governance, strategic direction, and long-term sustainability.